Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
A technical investigation has confirmed that ct1629b caz10 ceftazidime batch 1426486 may contain discs with a reduced concentration of antiboitic that may impact on perfromance.Testing with pseudoomonas aeruginosa atcc 27853 (eucast quality perfromance). continued used of this lot could result in quality control failures delayed results or incorrect results reporting (false resistance).